Guide Detoxification · How your liver reshapes foreign substances

Phase 1 and phase 2 of liver detoxification explained simply

Your liver does not simply flush anything out. It rebuilds, in several steps. And when the first step runs faster than the second, that explains many complaints better than any idea of accumulated waste.

Phase 1: cytochrome P450 Phase 2: conjugation Phase 3: transport Glutathione Evidence based
My starting point

The image of waste and slag piling up somewhere in the body is stubbornly persistent. In liver biochemistry it has no equivalent. What does exist there is a timing problem between two enzyme systems. And that is considerably more interesting.

The evening when everything suddenly felt like too much

Two coffees, one glass of red wine, and then this

Imagine you have a normal day. Two coffees in the morning, one of them large. In the evening one glass of red wine with dinner, nothing more.

At two in the morning you are lying awake. Your heart is beating too fast for that hour. Your head is pounding. You are tired and wired at the same time. The next morning you feel as if you had drunk a whole bottle.

"I barely drank anything. Why am I reacting like this?"

And two weeks later you do exactly the same thing. Nothing happens. All fine. That is the point at which many people start to doubt themselves.

An account like this from everyday clinical practice remains an observation. I cannot infer causality from this, I am only documenting the temporal association.

You are not oversensitive. And you are not imagining things.

What you are experiencing is a capacity issue. Caffeine and alcohol run on the same principle: they are first changed chemically, and only afterwards packaged so that the body can release them. When both steps mesh well, you notice nothing. When the first step is faster than the second, you notice a great deal.

To understand that, you need to know how detoxification actually works in your liver. It is not what is written on detox packaging.

Detoxification is not a flushing out. It is a rebuild.

Almost everything that is foreign to your body shares one problem. It is fat soluble. Medicines, alcohol, plasticisers, pesticide residues, mould toxins, but also the body's own hormones. Fat soluble substances feel at home in your cell membranes. They stay there.

And your most important exit, the kidney, works with water. It cannot release anything fat soluble.

Imagine a sofa that does not fit through the apartment door. You cannot carry it out, no matter how hard you try. You have to take it apart and rebuild it.

That is exactly what your liver does. In three steps.

1

Phase 1: the saw

Cytochrome P450 enzymes attach a reactive site to the molecule, usually by oxidation. The substance does not become more harmless. It becomes vulnerable to attack.

2

Phase 2: the handle

Conjugating enzymes couple a water soluble tag onto that site. Glucuronic acid, sulfate, glutathione, a methyl or an acetyl group. Now the substance can be transported.

3

Phase 3: the door

Transport proteins in the cell membrane move the finished package out of the liver cell. Into the bile and from there into the gut, or via the blood to the kidney.

The decisive sentence appears in almost every review on biotransformation, but rarely in consumer texts: these steps are only a detoxification process together. Taken on its own, phase 1 is not a cleaning step.

What the basic literature saysMechanism review

A widely cited review of the drug metabolising enzymes sums it up very clearly. The author describes how phase 1 enzymes such as CYP1A1, CYP1A2, CYP3A and CYP2E1 first convert certain foreign substances into highly reactive forms that can bind to DNA. Phase 2 enzymes such as glutathione S transferase and the glucuronyltransferases, by contrast, convert chemical carcinogens into less toxic or inactive products.

The most important sentence in it for you: the balance between activation and detoxification depends on the chemical structure of the substance, but also on genetic background, sex, hormonal status, age, diet and on which other substances happen to be in play.

Sheweita SA. Drug-metabolizing enzymes: mechanisms and functions. Curr Drug Metab. 2000. DOI: 10.2174/1389200003339117

And now you know why a single look at "the liver values" says so little. Those values measure cell damage. They do not measure how well your two rebuilding steps are matched to each other.

Phase 1: the saw that sometimes works too well

Phase 1 is carried by a large enzyme family. Cytochrome P450, CYP for short. Humans have around 57 functional genes of this kind. A few of them do the bulk of the work.

CYP1A2

Breaks down caffeine, plus aromatic amines and certain medicines. Clearly upregulated by smoking.

CYP3A4

The workhorse. Involved in the breakdown of a very large share of all medicines. Sensitive to inhibitors from food.

CYP2E1

Kicks in with higher alcohol consumption. Generates a particularly large number of free radicals in the process.

CYP1A1

Activates polycyclic aromatic hydrocarbons, of the kind found in smoke and heavily grilled food.

What these enzymes do sounds harmless: they attach an oxygen atom. Chemically speaking that is an attack. Intermediates arise that are more aggressive than the starting substance.

That is not a side effect. That is the purpose. The substance gets a handle that phase 2 can grip.

Reframe

Phase 1 is not a cleaning step. Phase 1 is an activation step.

If you read somewhere that a product "boosts phase 1 detoxification", that is not automatically good news. First of all it means more reactive intermediates. Whether that is helpful is decided in phase 2.

How seriously this point is taken can be seen in drug research. There, "bioactivation" is a field of its own.

Bioactivation as a known riskReview

A 2024 review examined 34 antidepressants to see whether reactive intermediates arise during their metabolism. Four of them were withdrawn from the market because of severe liver damage, others carry corresponding warnings.

The authors name reactive metabolites as one of the most frequently cited risk factors for drug induced liver injury. For you that means: it is not the active substance itself that is the problem, but what briefly becomes of it in phase 1.

Khalil SM et al. Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity. Drug Metab Rev. 2024. DOI: 10.1080/03602532.2024.2313967

Besides the CYP enzymes there is a second family in phase 1, the flavin monooxygenases. They usually work more gently and more often convert substances directly into readily excretable forms. Sometimes, though, they activate as well. No system is purely good or purely bad.

Phase 2: five routes, one goal

Phase 2 is the step almost nobody talks about. Yet it is the actual detoxification step.

Here a water soluble molecule is coupled to the site created by phase 1. This is called conjugation. The result is usually far less reactive and can be transported.

There are five major routes. They work in parallel, share substrates and can partly stand in for one another.

Glucuronidation

The largest route by volume. Glucuronic acid is attached. Affects bilirubin, many medicines, steroid hormones and thyroid hormones.

Enzymes: UDP glucuronosyltransferases (UGT)

Sulfation

A sulfate group is coupled on. Fast, but with limited capacity, because the sulfate supply is finite. Needs sulfur containing amino acids.

Enzymes: sulfotransferases (SULT)

Glutathione conjugation

The fire extinguisher. Catches precisely those reactive, electron hungry intermediates that would otherwise bind to DNA or proteins.

Enzymes: glutathione S transferases (GST)

Methylation

A methyl group is transferred. Important for catecholamines such as adrenaline and noradrenaline as well as for certain medicines.

Enzymes: COMT, TPMT and other methyltransferases

Acetylation

An acetyl group is attached. Here there are very clear genetic differences between fast and slow acetylators.

Enzymes: N acetyltransferases (NAT1, NAT2)

And the building blocks for it

Glycine, cysteine, methionine, taurine, glutamine, sulfur, glucuronic acid. Without these raw materials phase 2 stands still, no matter how good the enzymes are.

Origin: diet and metabolism
The standard review on phase 2Review

An often cited review from Olomouc worked systematically through exactly these enzyme families: glucuronosyltransferases, sulfotransferases, N acetyltransferases, glutathione S transferases and methyltransferases.

Two statements from it are relevant for you. First: these enzymes convert both foreign substances and the body's own compounds into more readily excretable forms. Second: reduced conjugation capacity may lead to clinically used medicines becoming toxic. Genetic differences play a large role in this.

Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap. 2010. DOI: 10.5507/bp.2010.017
To keep it honest

Phase 2 is not always simply harmless. With some substances a conjugation step can also produce a reactive product, for instance with certain sulfations and acetylations. The two phase model is a very useful picture, but it is a simplified picture.

The development across the lifespan is interesting too. In the unborn child, sulfation is the most developed route, while glucuronidation is still largely absent. It matures only after birth and for many enzymes reaches adult levels only in middle to late childhood.

It is not about having a "clean" body. It is about still having energy for your life in the evening.

The point that is usually missing: when phase 1 is faster than phase 2

Now comes the point that almost all consumer texts leave out.

The two phases do not run at a fixed ratio. They are regulated independently of each other. Phase 1 can be ramped up very easily. Smoking, alcohol, certain medicines, grilled meat, some herbal preparations. Phase 2, by contrast, depends on building blocks that have to be supplied.

When phase 1 runs at full throttle and phase 2 cannot keep up, the result is not nothing. The result is a backlog of reactive intermediates. And biologically that backlog is something quite different from the starting substance.

Exactly this imbalance is discussed in the specialist literature as a driver of oxidative stress. Not as an esoteric idea, but as a measurable state.

A look at real peopleHuman study, comparison groups

A South African research group studied young women who had long been taking a combined pill with drospirenone and ethinyl estradiol, and compared them with women not using hormonal preparations. What was measured was not just a single enzyme, but overall biotransformation performance using test substances.

The result: in the pill users, phase 1 activity via CYP1A2 was reduced, while the conjugation reactions via glucuronide and glycine were increased. At the same time serum peroxide levels were clearly raised and the antioxidant capacity of the plasma was lower. The women also reported moderate to strong exhaustion and more complaints overall.

What that means for you: the ratio between the two phases is not a theory. It is measurable in people, it shifts under everyday influences, and here that shift went along with increased oxidative stress. A study of this kind does not allow a statement about cause and effect.

Venter G et al. Health Status Is Affected, and Phase I/II Biotransformation Activity Altered in Young Women Using Oral Contraceptives Containing Drospirenone/Ethinyl Estradiol. Int J Environ Res Public Health. 2021. DOI: 10.3390/ijerph182010607

A second way into the same thought comes from genetics. Some people carry less phase 2 capacity from birth.

When a whole enzyme is missingReview

A relevant share of the population carries so called null genotypes in the glutathione S transferases GSTM1 or GSTT1. The corresponding enzyme is then not produced at all.

A review on renal cell carcinoma concludes that certain GST genotypes may act as risk modifiers, alone or in combination with other phase 1 and phase 2 gene variants, and particularly with corresponding exposure to pollutants. The authors phrase it exactly as the data allow: the results are heterogeneous, but the pattern is recognisable.

For you this does not mean you have a genetic testing problem. It means: people really are built differently here. Your tolerance threshold is not your friend's.

Pljesa-Ercegovac M et al. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma. BioFactors. 2019. DOI: 10.1002/biof.1560
Reframe

The usual story goes: "You have too many toxins in your body."

Closer to physiology is: your second layer is currently not keeping up.

That is a completely different starting point. With the first sentence you think of flushing out and getting rid of. With the second you think of capacity, of building blocks and of taking the load off. And the second sentence is the one where you actually have something in your hands.

Phase 3: the transport out, and why the gut has a say

A finished conjugate is not yet outside. It is sitting in the liver cell.

The last step needs transport proteins in the cell membrane. They belong to the ABC transporters and work using energy. The best known one in the liver is called MRP2. It sits on the membrane side facing the smallest bile ducts and moves the conjugates there.

From the bile it goes into the gut. And from there out with the stool. Another part leaves the body via the kidney.

What happens when phase 3 failsIn vivo, rat

There are rat strains that naturally lack the transporter Mrp2. A study at the University of Connecticut gave them paracetamol and followed the excretion of the breakdown products.

The paracetamol itself appeared in normal amounts in the bile. The glutathione conjugate, by contrast, was practically no longer detectable in the bile. Instead, the glutathione conjugate and the mercapturic acid derived from it accumulated in the liver.

That is the cleanest illustration of the principle I know of: phase 1 ran. Phase 2 ran. But without the door, the finished package stayed in the cell. This is an animal model, and in humans it has not been reproduced with this directness.

Chen C, Hennig GE, Manautou JE. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Drug Metab Dispos. 2003. DOI: 10.1124/dmd.31.6.798

The counter experiment is just as instructive. When a Japanese research group introduced the human MRP2 transporter into rat livers with defective Mrp2, the excretion of a test substance from blood into bile rose roughly threefold. Direct bilirubin in the blood also went down.

For everyday life this leads to a point that often gets lost: what goes via the bile ends up in the gut. And what stays lying in the gut has time. Bacterial enzymes can split certain conjugates apart again, and the released substance can be taken up once more. That is mechanistically well founded, but for many everyday substances it has not been quantified in large human studies.

That is why regular bowel movements belong, for me, in every conversation about detoxification. Not as a wellness topic. As a question of transport.

Not only the liver

The liver is the main site, but not the only one. A comprehensive review of the body's interfaces shows how differently they are equipped. In the lung, phase 1 enzymes dominate, while conjugation plays a smaller role there. In the skin it is the other way round, with mainly phase 2 enzymes. In the gut, CYP3A4 and CYP3A5 work together with many transporters. In the kidney, conjugation and transport are in the foreground.

That explains why some substances cause problems precisely where they touch the body, and not where you would expect them to.

Back to coffee and red wine

Now the scene from the beginning has a name.

The coffee: a single enzyme decides

Caffeine is broken down almost entirely via CYP1A2. Via a single phase 1 enzyme, in other words. That is why caffeine is used as a probe in research: the ratio of paraxanthine to caffeine in the blood is measured, and that tells you fairly precisely how actively CYP1A2 is currently working.

How much this variesHuman study, n=194, longitudinal

A Swiss research group studied 194 people who smoked, and 118 of them again after they had not smoked for four weeks.

People who smoked had on average a 1.55 fold higher CYP1A2 activity. The individual decline after stopping smoking ranged from no change at all to a drop by a factor of 7.3. The number of cigarettes per day, the use of hormonal contraceptives and several gene variants also clearly influenced the activity.

Translated: two people drink the same espresso. In one of them it is gone within a few hours. In the other, half of it is still in the blood in the evening. Both are healthy.

Dobrinas M et al. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin Pharmacol Ther. 2011. DOI: 10.1038/clpt.2011.70

One detail about this is remarkable. Smoking makes CYP1A2 faster. So it makes phase 1 more capable. By simple consumer logic, smoking would therefore have to "support detoxification". That is exactly where you can see why this logic does not hold. What counts is the ratio to phase 2.

The red wine: the intermediate is the problem

Alcohol is first converted into acetaldehyde. Acetaldehyde is a highly reactive molecule. It binds to proteins and to DNA. It is the substance held responsible for a good part of what you feel the morning after.

The second step is the enzyme ALDH2. It breaks acetaldehyde down further. Strictly speaking ALDH2 is not a conjugating enzyme but a further oxidation. The principle is the same nonetheless: a reactive intermediate needs a reliable second step.

8 %of the world population carry the restricted ALDH2 variant
35 to 45 %of people of East Asian descent are affected
7 to 12 foldincreased risk of oesophageal cancer with regular consumption
An intermediate with consequencesReview

A review from Weill Cornell Medical College describes the ALDH2 variant E487K very precisely. In carriers, acetaldehyde builds up systemically after alcohol consumption. Acutely this shows up as flush syndrome: facial flushing, a racing heart, nausea, headache.

With chronic consumption the variant is linked to a strongly increased risk of cancers in the upper digestive and respiratory tract. According to this review, homozygous individuals with moderate to high alcohol consumption have a 7 to 12 fold increased risk of oesophageal cancer. An independent paper from Stanford puts the number of people affected worldwide at around 540 million.

The point for you: alcohol alone does not decide this. The capacity of the second step has a say.

Montel RA et al. Cancer Gene Ther. 2022. DOI: 10.1038/s41417-021-00399-1 · McAllister SL, Sun K, Gross ER. J Biomed Sci. 2016. DOI: 10.1186/s12929-016-0299-3

And now the scene from the beginning comes together. On the same evening, phase 1 is running flat out in two places at once. Caffeine via CYP1A2, alcohol via alcohol dehydrogenase and, with higher consumption, additionally via CYP2E1. Both produce intermediates that have to be processed further. If glutathione, sulfate and the amino acid stores are already short that day because you ate little, slept badly and worked a lot, then you notice it.

Two weeks later, well rested and well supplied, you notice nothing. Same amount, different outcome.

Reframe

You are not "intolerant". Your tolerance is not a fixed property.

It is a daily value. It depends on how much phase 2 capacity you have available on that day. That is good news, because daily values can be influenced.

Paracetamol: the textbook case

When I want to show the phase principle in a single example, I take paracetamol. Not as a warning against the medicine, but because it is the best studied case there is.

At usual doses, by far the largest part is processed directly in phase 2, via glucuronidation and sulfation. A small proportion runs via phase 1 enzymes and becomes NAPQI, a highly reactive intermediate. This NAPQI is caught by glutathione and excreted as a conjugate. Nobody notices anything.

At a very high dose the system tips over. The conjugation routes are saturated. More substance runs via phase 1. More NAPQI arises, and the glutathione stores are used up. Only then does cell damage occur.

What the reviews say about thisMechanism review

A 2023 review describes the chain exactly like this: excessive paracetamol metabolism uses up glutathione and increases NAPQI, which can lead to oxidative stress, DNA damage and cell death in the liver.

A second, independent toxicological assessment arrives at the same picture and adds an important point: at the recommended therapeutic doses only a small amount of NAPQI arises, without harmful effects on the cell. The problem is the saturation of the phase 2 routes, not the substance as such.

That is precisely why the antidote in overdose is a cysteine supplier for new glutathione production. You do not top up phase 1. You top up phase 2.

Liao J et al. Front Pharmacol. 2023. DOI: 10.3389/fphar.2023.1122632 · Jaeschke H et al. Regul Toxicol Pharmacol. 2021. DOI: 10.1016/j.yrtph.2020.104859

And now you know why, with people who have many intolerances, I rarely ask "What are you taking in?" and almost always "What are you supplying your second layer with?".

The four lenses of clinical psychoneuroimmunology on one and the same liver

In clinical psychoneuroimmunology we habitually look through four lenses. With biotransformation they interlock unusually strongly.

Nervous system

Sleep is not a side issue. People who sleep badly drink more coffee. More coffee with slow CYP1A2 means more caffeine in the blood at bedtime. The circle closes and tightens. On top of that: methylation is the same route by which adrenaline and noradrenaline are broken down. Under ongoing stress, many requests arrive there at once.

Immune system

Reactive intermediates bind to proteins. In the process, new structures unfamiliar to the immune system can arise. Exactly this is discussed as one possible mechanism in drug induced liver reactions. It is plausible and established in toxicology, but for individual everyday substances it has not been conclusively clarified.

Metabolism

Phase 2 consumes material. Glycine, cysteine, methionine, taurine, glutamine, sulfur, glucuronic acid. People who eat very little protein, fast for very long periods or live chronically in a deficit have less of it. The enzymes are there, but without resupply.

Hormonal system

Oestrogens, thyroid hormones and cortisol breakdown products themselves run via glucuronidation and sulfation. So they are not only regulators, they are also customers. When foreign substances are added on top, both share the same queue.

That is why it is not a quirk to talk about the gut with hormonal complaints, or about protein supply with exhaustion. It is the same metabolic pathway, only viewed from another side.

Three levers that really count in everyday life

I deliberately give no recipes here. Doses and sequences belong in a conversation with findings on the table, not in a blog article. What I can give you are directions.

Lever 1: cruciferous vegetables, regularly instead of as a short programme

Broccoli, Brussels sprouts, kohlrabi, cress, rocket, mustard. They contain glucosinolates, from which sulforaphane among others arises. Sulforaphane activates a cellular switch called Nrf2, which can ramp up the production of antioxidant and conjugating enzymes, including glutathione S transferases.

What is special about this: here there is not only cell culture data, but measured excretion in humans.

Randomised study with excretion as the endpointRCT, n=291

In Qidong in China, a region with high air pollution, 291 people received either a daily broccoli sprout beverage or placebo for twelve weeks. What was measured was the excretion of mercapturic acids in urine, in other words precisely the end products of glutathione conjugation.

In the active group, excretion of the benzene conjugate rose by 61 percent and that of the acrolein conjugate by 23 percent, statistically significant and stable across the whole study period. With crotonaldehyde there was no effect. Interesting: excretion of the benzene conjugate was higher in people with an intact GSTT1 gene than in those with null genotypes, independently of group allocation.

An earlier crossover study by the same group with 50 participants found increases in the same direction of 20 to 50 percent. Two independent studies, the same signal. This is not a detox programme. It is a measurably increased conjugation capacity.

Egner PA et al. Cancer Prev Res. 2014. DOI: 10.1158/1940-6207.CAPR-14-0103 · Kensler TW et al. Carcinogenesis. 2012. DOI: 10.1093/carcin/bgr229

Lever 2: the building blocks for phase 2

Glutathione is not a store that you either have or do not have. It is an ongoing production. How much comes out of it depends above all on two things: on the availability of the amino acid cysteine and on the activity of the rate limiting enzyme glutamate cysteine ligase. Both are well studied.

In practical terms that means: enough protein across the day, sulfur containing foods, and not living permanently in a strong caloric deficit. For glycine conjugation, protein sources rich in connective tissue are interesting. That is unspectacular and for exactly that reason so often overlooked.

Lever 3: keep the exit open and do not keep fuelling phase 1

What goes via the bile also has to leave the gut. Regular bowel movements, enough fluid, enough fibre. That is the phase 3 part.

And the other part: nicotine, high alcohol consumption and a lot of caffeine late in the day keep phase 1 at a high level. If you are at a point where you react sensitively to many things, it can make more sense to ease off the accelerator a little rather than press it down harder.

Self check: signs of a capacity issue

  • You tolerate coffee or alcohol well on some days and not at all on others.
  • You react to fragrances, cleaning products or paint smells more strongly than others do.
  • Medicines at a normal dose often feel too strong for you.
  • You sleep badly even though you had your last coffee early in the day.
  • Your digestion is sluggish and you rarely have a daily bowel movement.
  • You eat little protein, often fast for long periods or are in a dieting phase.
  • In your family there are people with a striking reaction to alcohol or medicines.

Several ticks are not a diagnosis. They are a good reason to look at the topic properly for once, instead of continuing to dismiss it as sensitivity.

What is established, and where my own view begins

The distinction that matters to me

  • Well established: the existence and function of the enzyme families, bioactivation in phase 1, the conjugation routes in phase 2, the role of the ABC transporters in phase 3, the genetic differences in GST, NAT and ALDH2, the effect of smoking on CYP1A2, the paracetamol mechanism, and the increased excretion of pollutant conjugates with broccoli sprouts.
  • Mechanistically plausible, human data thinner: how strongly an imbalance between the phases affects general wellbeing in everyday life. There are studies such as the South African work on pill users, but no large intervention trials with wellbeing as the endpoint.
  • Clinical observation without a strong study basis: that many people with multiple intolerances benefit noticeably when protein supply, sleep and routes of excretion are addressed first. That is my experience. I describe it as an observation, not as proof.
  • Debated and difficult in everyday practice: routine measurement of phase 1 and phase 2 activity. Functional test procedures using caffeine and other probes exist and are scientifically established. They are not standard in routine care.

Classical hepatology looks primarily at structure and damage. That is sensible and important, because a fatty liver or a hepatitis has to be recognised. What a functional and cPNI oriented view can add is the question of capacity: not whether the liver is diseased, but how much rebuilding work it can do under the current conditions.

Both questions are legitimate. They do not exclude each other.

Frequently asked questions about phase 1 and phase 2

What is the difference between phase 1 and phase 2 of liver detoxification?

Phase 1 changes a substance chemically, phase 2 packages it. In phase 1, cytochrome P450 enzymes above all attach a reactive group to the molecule, usually by oxidation. This does not make the substance more harmless, it makes it more vulnerable to attack. In phase 2, conjugating enzymes couple a water soluble tag onto it, for example glucuronic acid, sulfate, glutathione, a methyl group or an acetyl group. Only after that can the body release the substance via bile or urine. Both steps only make sense together.

Why can phase 1 make a substance more dangerous than it was before?

Because oxidation creates reactive intermediates. Reviews on biotransformation describe how cytochrome P450 enzymes first convert certain substances into forms that can bind to DNA or proteins. Well known examples are polycyclic aromatic hydrocarbons, aromatic amines and aflatoxin B1. This is called metabolic activation or bioactivation. Whether it becomes a problem depends on how quickly phase 2 catches these intermediates again.

What happens when phase 1 and phase 2 are out of balance?

When phase 1 works faster than phase 2 can keep up, reactive intermediates may accumulate. In the specialist literature this is discussed as a cause of increased oxidative stress. A South African study in young women on a combined oral contraceptive showed exactly such a shift: altered phase 1 activity, altered conjugation capacity, plus raised serum peroxide levels, lower antioxidant capacity and more reported exhaustion. That is not proof of cause and effect, but it is a well measurable association.

What exactly does phase 3 of detoxification do?

Phase 3 is the transport out. Specialised proteins in the cell membrane, above all ABC transporters such as MRP2, move the substances packaged in phase 2 out of the liver cell and into the bile. From there they go into the gut and leave with the stool. Another part leaves the body via the kidney with the urine. Animal experiments show this very clearly: rats without a working Mrp2 barely excrete the glutathione conjugate of paracetamol via the bile any more, it accumulates in the liver instead.

What role does glutathione play in phase 2?

Glutathione is the fire extinguisher for reactive intermediates. Glutathione S transferases couple it to electrophilic molecules that would otherwise bind to cell structures. Through several intermediate steps the result becomes what are known as mercapturic acids and is released via the urine. New glutathione production depends strongly on the availability of the amino acid cysteine and on the activity of the key enzyme glutamate cysteine ligase. That is why glutathione is not an unlimited store, it is an ongoing production.

Why do some people react so strongly to coffee?

Caffeine is broken down almost entirely by a single phase 1 enzyme, CYP1A2. Its activity varies considerably between people. In a study of 194 smokers, CYP1A2 activity was on average 1.55 fold higher than in non smokers. After four weeks without smoking it dropped individually by up to 7.3 fold. Hormonal contraception and certain gene variants also influenced the activity. Two people can drink the same espresso and have it in their blood for completely different lengths of time.

Why do some people tolerate alcohol so poorly?

Alcohol is first converted into acetaldehyde, a highly reactive intermediate. Acetaldehyde is then processed further by the enzyme ALDH2. Around 8 percent of the world population and 35 to 45 percent of people of East Asian descent carry a variant in which ALDH2 works only to a limited degree. Acetaldehyde then builds up. Typical signs are facial flushing, a racing heart, nausea and headache. With regular consumption this variant is also linked to a clearly increased risk of oesophageal cancer.

Can phase 1 and phase 2 be measured in the laboratory?

Partly yes, but it is not routine laboratory work. In research, test substances with known breakdown routes are used. Caffeine is regarded as an established probe for CYP1A2, and the ratio of paraxanthine to caffeine is measured. For conjugation steps, glucuronide and glycine conjugates in urine are among the markers determined. Such functional tests are informative, but they are standardised and expensive. In ordinary practice, the history, the medication list and the pattern of tolerance often already say a great deal.

Do detox programmes, teas or patches help with liver detoxification?

For the classic detox products there is hardly any robust human data, and the image of waste being flushed out has no equivalent in liver biochemistry. What studies do show: certain plant compounds can measurably influence conjugation capacity. In a randomised study in China with 291 participants, excretion of the glutathione conjugate of benzene rose by 61 percent with a broccoli sprout beverage. That is not a miracle product, but it is a measurable effect on phase 2.

What can support phase 2 in everyday life?

Phase 2 works with building blocks that come from metabolism. These include amino acids such as glycine, cysteine, methionine and taurine as well as sulfur and glucuronic acid. An adequate protein supply is therefore not a side issue. Regular cruciferous vegetables such as broccoli, Brussels sprouts and cress can upregulate conjugating enzymes via the Nrf2 pathway. And an open route of excretion counts: regular bowel movements and drinking enough. At the same time it can make sense not to keep fuelling phase 1 on top of everything else.

If you want to go deeper

This article belongs to the Guide Detoxification. The following texts pick out individual building blocks and go into more depth there.

SJ
About the author

Shukri Jarmoukli

Physician, Integrative Medicine · ViveCura Berlin

I work at the interface of conventional medicine and clinical psychoneuroimmunology. I am less interested in which product is currently being advertised, and more in the question of how much capacity a body actually has under its current conditions.

This text does not replace medical advice. It is meant to give you a language for what you observe in yourself.

ViveCura · Skalitzer Straße 137, Berlin

Sources

All statements were checked via PubMed. The central claims on bioactivation, conjugation, phase imbalance and sulforaphane are each backed by at least two independent papers.

  1. Sheweita SA. Drug-metabolizing enzymes: mechanisms and functions. Curr Drug Metab. 2000;1(2):107-32. DOI: 10.2174/1389200003339117 [Mechanism review]
  2. Jancova P, Anzenbacher P, Anzenbacherova E. Phase II drug metabolizing enzymes. Biomed Pap Med Fac Univ Palacky Olomouc Czech Repub. 2010;154(2):103-16. DOI: 10.5507/bp.2010.017 [Review]
  3. Venter G, van der Berg CL, van der Westhuizen FH, Erasmus E. Health Status Is Affected, and Phase I/II Biotransformation Activity Altered in Young Women Using Oral Contraceptives Containing Drospirenone/Ethinyl Estradiol. Int J Environ Res Public Health. 2021;18(20):10607. DOI: 10.3390/ijerph182010607 [Real-world, human study with comparison group]
  4. Egner PA, Chen JG, Zarth AT et al. Rapid and sustainable detoxication of airborne pollutants by broccoli sprout beverage: results of a randomized clinical trial in China. Cancer Prev Res (Phila). 2014;7(8):813-823. DOI: 10.1158/1940-6207.CAPR-14-0103 [RCT, n=291, 12 weeks]
  5. Kensler TW, Ng D, Carmella SG et al. Modulation of the metabolism of airborne pollutants by glucoraphanin-rich and sulforaphane-rich broccoli sprout beverages in Qidong, China. Carcinogenesis. 2012;33(1):101-7. DOI: 10.1093/carcin/bgr229 [RCT, crossover, n=50]
  6. Dobrinas M, Cornuz J, Oneda B et al. Impact of smoking, smoking cessation, and genetic polymorphisms on CYP1A2 activity and inducibility. Clin Pharmacol Ther. 2011;90(1):117-25. DOI: 10.1038/clpt.2011.70 [Real-world, longitudinal, n=194]
  7. Tian DD, Natesan S, White JR, Paine MF. Effects of Common CYP1A2 Genotypes and Other Key Factors on Intraindividual Variation in the Caffeine Metabolic Ratio. Clin Transl Sci. 2019;12(1):39-46. DOI: 10.1111/cts.12598 [Real-world, controlled human study, n=24]
  8. Montel RA, Munoz-Zuluaga C, Stiles KM, Crystal RG. Can gene therapy be used to prevent cancer? Gene therapy for aldehyde dehydrogenase 2 deficiency. Cancer Gene Ther. 2022;29(7):889-896. DOI: 10.1038/s41417-021-00399-1 [Review]
  9. McAllister SL, Sun K, Gross ER. Developing precision medicine for people of East Asian descent. J Biomed Sci. 2016;23(1):80. DOI: 10.1186/s12929-016-0299-3 [Review]
  10. Liao J, Lu Q, Li Z et al. Acetaminophen-induced liver injury: Molecular mechanism and treatments from natural products. Front Pharmacol. 2023;14:1122632. DOI: 10.3389/fphar.2023.1122632 [Mechanism review]
  11. Jaeschke H, Murray FJ, Monnot AD et al. Assessment of the biochemical pathways for acetaminophen toxicity: Implications for its carcinogenic hazard potential. Regul Toxicol Pharmacol. 2021;120:104859. DOI: 10.1016/j.yrtph.2020.104859 [Review, toxicological assessment]
  12. Chen C, Hennig GE, Manautou JE. Hepatobiliary excretion of acetaminophen glutathione conjugate and its derivatives in transport-deficient (TR-) hyperbilirubinemic rats. Drug Metab Dispos. 2003;31(6):798-804. DOI: 10.1124/dmd.31.6.798 [In vivo, rat]
  13. Hirouchi M, Suzuki H, Sugiyama Y. Treatment of hyperbilirubinemia in Eisai hyperbilirubinemic rat by transfecting human MRP2/ABCC2 gene. Pharm Res. 2005;22(4):661-6. DOI: 10.1007/s11095-005-2502-1 [In vivo, rat]
  14. Pljesa-Ercegovac M, Savic-Radojevic A, Coric V, Radic T, Simic T. Glutathione transferase genotypes may serve as determinants of risk and prognosis in renal cell carcinoma. BioFactors. 2019;46(2):229-238. DOI: 10.1002/biof.1560 [Review]
  15. Khalil SM, MacKenzie KR, Maletic-Savatic M, Li F. Metabolic bioactivation of antidepressants: advance and underlying hepatotoxicity. Drug Metab Rev. 2024;56(2):97-126. DOI: 10.1080/03602532.2024.2313967 [Review]
  16. Tang LWT, Chan ECY. Metabolic activation of drugs by cytochrome P450 enzymes. Biochem Pharmacol. 2022;206:115336. DOI: 10.1016/j.bcp.2022.115336 [Mechanism review]
  17. Cashman JR, Zhang J. Human flavin-containing monooxygenases. Annu Rev Pharmacol Toxicol. 2006;46:65-100. DOI: 10.1146/annurev.pharmtox.46.120604.141043 [Review]
  18. Coughtrie MWH. Ontogeny of Human Conjugating Enzymes. Drug Metab Lett. 2015;9(2):99-108. DOI: 10.2174/1872312809666150602151213 [Review]
  19. Gundert-Remy U, Bernauer U, Blömeke B et al. Extrahepatic metabolism at the body's internal-external interfaces. Drug Metab Rev. 2014;46(3):291-324. DOI: 10.3109/03602532.2014.900565 [Review]
  20. Lu SC. Glutathione synthesis. Biochim Biophys Acta. 2013;1830(5):3143-53. DOI: 10.1016/j.bbagen.2012.09.008 [Mechanism review]
  21. Qin S, Hou DX. Multiple regulations of Keap1/Nrf2 system by dietary phytochemicals. Mol Nutr Food Res. 2016;60(8):1731-55. DOI: 10.1002/mnfr.201501017 [Mechanism review]
Transparency note on the evidence The enzyme biology of phase 1, phase 2 and phase 3 is very well studied. The statements on bioactivation, on the conjugation routes and on the genetic differences rest on established reviews. The data on increased pollutant excretion with broccoli sprouts come from two randomised studies in humans. For the phase 3 transporters the clearest evidence comes from animal models; in humans the mechanism is well founded but has not been reproduced with this directness. For the question of how strongly a phase imbalance affects general wellbeing, no large intervention trials exist so far. The associations described here are biologically plausible, but on this point they are not established with the same certainty as through large randomised trials.

Have questions or want to book an appointment?

We'd be happy to advise you personally at our practice.

Book appointment